IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus

Sci Adv. 2023 Sep 15;9(37):eadi2562. doi: 10.1126/sciadv.adi2562. Epub 2023 Sep 13.

Abstract

Norovirus is a leading cause of epidemic viral gastroenteritis, with no currently approved vaccines or antivirals. Murine norovirus (MNoV) is a well-characterized model of norovirus pathogenesis in vivo, and persistent strains exhibit lifelong intestinal infection. Interferon-λ (IFN-λ) is a potent antiviral that rapidly cures MNoV. We previously demonstrated that IFN-λ signaling in intestinal epithelial cells (IECs) controls persistent MNoV, and here demonstrate that IFN-λ acts on tuft cells, the exclusive site of MNoV persistence, to limit infection. While interrogating the source of IFN-λ to regulate MNoV, we confirmed that MDA5-MAVS signaling, required for IFN-λ induction to MNoV in vitro, controls persistent MNoV in vivo. We demonstrate that MAVS in IECs and not immune cells controls MNoV. MAVS in nonsusceptible enterocytes, but not in tuft cells, restricts MNoV, implicating noninfected cells as the IFN-λ source. Our findings indicate that host sensing of MNoV is distinct from cellular tropism, suggesting intercellular communication between IECs for antiviral signaling induction in uninfected bystander cells.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Enterocytes
  • Enterovirus Infections*
  • Epithelial Cells
  • Interferon Lambda
  • Mice
  • Norovirus*
  • Signal Transduction

Substances

  • Antiviral Agents
  • Interferon Lambda